Agreed. I would prefer to have the BLA submission correct and complete rather than soon. We are all impatient and invested in this process and outcome but missing the mark on the BLA due to hurrying isn't a good outcome for anyone.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-846
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.080(6.43%) |
Mkt cap ! $1.512B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $12.87M | 9.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 36052 | $1.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.34 | 109530 | 7 |
View Market Depth
| Last trade - 13.45pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |